久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/10/13 | 3,610 | 3,880 | 3,580 | 3,805 | +460 | +13.8% | 1,107,800 |
| 2022/10/12 | 3,365 | 3,390 | 3,345 | 3,345 | -20 | -0.6% | 131,500 |
| 2022/10/11 | 3,365 | 3,405 | 3,355 | 3,365 | -60 | -1.8% | 190,900 |
| 2022/10/07 | 3,380 | 3,445 | 3,380 | 3,425 | +5 | +0.1% | 153,200 |
| 2022/10/06 | 3,445 | 3,475 | 3,420 | 3,420 | -30 | -0.9% | 167,300 |
| 2022/10/05 | 3,485 | 3,495 | 3,430 | 3,450 | -35 | -1% | 152,900 |
| 2022/10/04 | 3,410 | 3,495 | 3,410 | 3,485 | +145 | +4.3% | 289,300 |
| 2022/10/03 | 3,350 | 3,375 | 3,310 | 3,340 | -55 | -1.6% | 184,300 |
| 2022/09/30 | 3,420 | 3,465 | 3,385 | 3,395 | -20 | -0.6% | 204,200 |
| 2022/09/29 | 3,345 | 3,420 | 3,330 | 3,415 | +120 | +3.6% | 213,700 |
| 2022/09/28 | 3,270 | 3,310 | 3,265 | 3,295 | +30 | +0.9% | 248,700 |
| 2022/09/27 | 3,260 | 3,285 | 3,230 | 3,265 | +10 | +0.3% | 218,800 |
| 2022/09/26 | 3,265 | 3,285 | 3,240 | 3,255 | -30 | -0.9% | 229,800 |
| 2022/09/22 | 3,300 | 3,310 | 3,260 | 3,285 | -50 | -1.5% | 176,600 |
| 2022/09/21 | 3,365 | 3,380 | 3,335 | 3,335 | -55 | -1.6% | 137,100 |
| 2022/09/20 | 3,460 | 3,460 | 3,390 | 3,390 | -35 | -1% | 110,000 |
| 2022/09/16 | 3,385 | 3,430 | 3,385 | 3,425 | +15 | +0.4% | 103,100 |
| 2022/09/15 | 3,400 | 3,425 | 3,385 | 3,410 | +10 | +0.3% | 82,100 |
| 2022/09/14 | 3,410 | 3,430 | 3,395 | 3,400 | -80 | -2.3% | 133,600 |
| 2022/09/13 | 3,485 | 3,505 | 3,445 | 3,480 | -25 | -0.7% | 127,000 |
| 2022/09/12 | 3,545 | 3,545 | 3,485 | 3,505 | +5 | +0.1% | 112,300 |
| 2022/09/09 | 3,470 | 3,515 | 3,470 | 3,500 | +30 | +0.9% | 217,600 |
| 2022/09/08 | 3,410 | 3,480 | 3,400 | 3,470 | +80 | +2.4% | 242,000 |
| 2022/09/07 | 3,425 | 3,430 | 3,350 | 3,390 | -30 | -0.9% | 173,700 |
| 2022/09/06 | 3,420 | 3,460 | 3,410 | 3,420 | -15 | -0.4% | 95,000 |
| 2022/09/05 | 3,430 | 3,455 | 3,410 | 3,435 | -10 | -0.3% | 114,900 |
| 2022/09/02 | 3,440 | 3,470 | 3,415 | 3,445 | +60 | +1.8% | 247,900 |
| 2022/09/01 | 3,355 | 3,415 | 3,355 | 3,385 | -5 | -0.1% | 128,300 |
| 2022/08/31 | 3,360 | 3,400 | 3,360 | 3,390 | -5 | -0.1% | 139,900 |
| 2022/08/30 | 3,345 | 3,395 | 3,345 | 3,395 | ±0 | ±0% | 160,600 |
| 2022/08/29 | 3,360 | 3,405 | 3,350 | 3,395 | -30 | -0.9% | 366,300 |
| 2022/08/26 | 3,440 | 3,440 | 3,410 | 3,425 | -10 | -0.3% | 124,600 |
| 2022/08/25 | 3,415 | 3,440 | 3,410 | 3,435 | +30 | +0.9% | 96,100 |
| 2022/08/24 | 3,405 | 3,425 | 3,395 | 3,405 | -10 | -0.3% | 93,000 |
| 2022/08/23 | 3,415 | 3,430 | 3,405 | 3,415 | -40 | -1.2% | 99,300 |
| 2022/08/22 | 3,435 | 3,455 | 3,420 | 3,455 | ±0 | ±0% | 114,900 |
| 2022/08/19 | 3,455 | 3,465 | 3,425 | 3,455 | +40 | +1.2% | 129,500 |
| 2022/08/18 | 3,450 | 3,455 | 3,410 | 3,415 | -40 | -1.2% | 86,700 |
| 2022/08/17 | 3,440 | 3,455 | 3,420 | 3,455 | +30 | +0.9% | 119,000 |
| 2022/08/16 | 3,445 | 3,445 | 3,405 | 3,425 | -10 | -0.3% | 122,100 |
| 2022/08/15 | 3,440 | 3,465 | 3,430 | 3,435 | +25 | +0.7% | 145,200 |
| 2022/08/12 | 3,420 | 3,450 | 3,390 | 3,410 | -5 | -0.1% | 147,300 |
| 2022/08/10 | 3,350 | 3,415 | 3,340 | 3,415 | +75 | +2.2% | 132,500 |
| 2022/08/09 | 3,370 | 3,385 | 3,340 | 3,340 | -35 | -1% | 231,100 |
| 2022/08/08 | 3,400 | 3,400 | 3,370 | 3,375 | -40 | -1.2% | 99,300 |
| 2022/08/05 | 3,385 | 3,425 | 3,380 | 3,415 | +10 | +0.3% | 115,400 |
| 2022/08/04 | 3,420 | 3,425 | 3,385 | 3,405 | +30 | +0.9% | 131,800 |
| 2022/08/03 | 3,375 | 3,405 | 3,360 | 3,375 | ±0 | ±0% | 142,400 |
| 2022/08/02 | 3,490 | 3,490 | 3,375 | 3,375 | -145 | -4.1% | 222,000 |
| 2022/08/01 | 3,455 | 3,530 | 3,440 | 3,520 | +60 | +1.7% | 137,100 |
701～
750
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 428,400円 | +5.8% | +1.2% | 2.80% | 13.87倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 140,700円 | -11.0% | +206.6% | 0.00% | 13.97倍 | 3.30倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 156,700円 | -2.0% | -7.3% | 2.43% | 15.32倍 | 1.82倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 361,300円 | +3.8% | -19.9% | 3.76% | 11.74倍 | 0.90倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 322,200円 | +3.6% | -15.3% | 3.85% | 9.05倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
